{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T11:12:17Z","timestamp":1771413137600,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jfma.2023.10.018","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T10:29:42Z","timestamp":1700216982000},"page":"693-700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The seroepidemiology of isolated core antibody against hepatitis B among Taiwanese adults - A large hospital-based study"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3925-138X","authenticated-orcid":false,"given":"Ting-Ya","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry Che-Jui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Chu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2893-2187","authenticated-orcid":false,"given":"Chyi-Feng","family":"Jan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.10.018_bib1","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/jama.1987.03390190075023","article-title":"A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen\u2014carrier mothers","volume":"257","author":"Chen","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2023.10.018_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0929-6646(07)60001-1","article-title":"Seroprevalence of hepatitis B viral markers among freshmen--20 years after mass hepatitis B vaccination program in Taiwan","volume":"106","author":"Chang","year":"2007","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2023.10.018_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/epirev\/mxj010","article-title":"Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 Years after it was launched","volume":"28","author":"Chien","year":"2006","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jfma.2023.10.018_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1086\/314585","article-title":"Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization","volume":"179","author":"Hsu","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfma.2023.10.018_bib5","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cgh.2016.04.030","article-title":"Continuing decrease in hepatitis B virus infection 30 Years after initiation of infant vaccination program in Taiwan","volume":"14","author":"Ni","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2023.10.018_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jhep.2012.05.021","article-title":"Minimization of hepatitis B infection by a 25-year universal vaccination program","volume":"57","author":"Ni","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2023.10.018_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/jcm9010202","article-title":"Isolated anti-HBc: significance and management","volume":"9","author":"Moretto","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jfma.2023.10.018_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00705-009-0559-6","article-title":"The underlying mechanisms for the \u2018anti-HBc alone\u2019 serological profile","volume":"155","author":"Pond\u00e9","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2023.10.018_bib10","first-page":"1165","article-title":"High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum","volume":"81","author":"Weinberger","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.1995.tb01077.x","article-title":"Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc","volume":"10","author":"Chan","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2023.10.018_bib12","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1016\/j.vaccine.2012.04.031","article-title":"Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan","volume":"30","author":"Su","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2023.10.018_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y","article-title":"Serological pattern \u201canti-HBc alone\u201d: report on a workshop","volume":"62","author":"Grob","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib14","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1537-2995.2001.41050652.x","article-title":"Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece","volume":"41","author":"Zervou","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.jfma.2023.10.018_bib15","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/hep.1840080411","article-title":"Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs","volume":"8","author":"Lok","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2023.10.018_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000025026","article-title":"High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen","volume":"43","author":"Berger","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.jfma.2023.10.018_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4254\/wjh.v6.i12.860","article-title":"Occult hepatitis B virus infection","volume":"6","author":"Kwak","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jfma.2023.10.018_bib18","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/infdis\/jiw011","article-title":"Vaccination against hepatitis B virus (HBV) in HIV-1\u2013Infected patients with isolated anti\u2013HBV core antibody: the ANRS HB EP03 CISOVAC prospective study","volume":"213","author":"Piroth","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfma.2023.10.018_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13104-019-4287-z","article-title":"The prevalence and significance of isolated hepatitis B core antibody (anti-HBc) in endemic population","volume":"12","author":"Hyun","year":"2019","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jfma.2023.10.018_bib20","first-page":"760","article-title":"Hepatitis B virus infection in Taiwan with reference to anti-HBc versus HBsAg and anti-HBs","volume":"79","author":"Wu","year":"1980","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"key":"10.1016\/j.jfma.2023.10.018_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/hep.510290120","article-title":"Kinetics of hepatitis B surface antigen\u2013specific immune responses in acute and chronic hepatitis B or after HBs vaccination: Stimulation of the in vitro antibody response by interferon gamma","volume":"29","author":"B\u00f6cher","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2023.10.018_bib22","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1128\/JVI.80.7.3506-3514.2006","article-title":"Partial Delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen","volume":"80","author":"Desombere","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2249.1996.d01-732.x","article-title":"Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection","volume":"105","author":"B\u00f6cher","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jfma.2023.10.018_bib24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2005.08.058","article-title":"Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination","volume":"24","author":"Bauer","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2023.10.018_bib25","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.inf.0000130952.96259.fd","article-title":"Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth","volume":"23","author":"Petersen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jfma.2023.10.018_bib26","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0016-5085(92)90851-O","article-title":"Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen","volume":"103","author":"McMahon","year":"1992","journal-title":"Gastroenterol"},{"key":"10.1016\/j.jfma.2023.10.018_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.510310232","article-title":"Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen","volume":"31","author":"Marusawa","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2023.10.018_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0042-9007.2004.00406.x","article-title":"Occult hepatitis B virus infection: implications in transfusion","volume":"86","author":"Allain","year":"2004","journal-title":"Vox Sang"},{"key":"10.1016\/j.jfma.2023.10.018_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2023.10.018_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2012.04.021","article-title":"High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG","volume":"57","author":"Shahmoradi","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2023.10.018_bib31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jvh.12102","article-title":"Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial","volume":"20","author":"Pande","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jfma.2023.10.018_bib32","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1016\/j.vaccine.2010.06.106","article-title":"Occult HBV infection in anti-HBs-positive young adults after neonatal HB vaccination","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2023.10.018_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00126334-200312010-00013","article-title":"Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen","volume":"34","author":"Gandhi","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jfma.2023.10.018_bib34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jmv.1052","article-title":"Hepatitis B virus markers in anti-HBc only positive individuals","volume":"64","author":"Weber","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jmv.10432","article-title":"Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection","volume":"70","author":"Rodr\u00edguez-I\u00f1igo","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","article-title":"Vaccine-induced escape mutant of hepatitis B virus","volume":"336","author":"Carman","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2023.10.018_bib37","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/jvi.68.4.2671-2676.1994","article-title":"Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen","volume":"68","author":"Yamamoto","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/651378","article-title":"No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization","volume":"201","author":"Hsu","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfma.2023.10.018_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jcv.2012.04.027","article-title":"HBsAg variants: diagnostic-escape and diagnostic dilemma","volume":"57","author":"Alavian","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2023.10.018_bib41","first-page":"1","article-title":"Epidemiological study on hepatitis B virus infection in Taiwan","volume":"1","author":"Sung","year":"1984","journal-title":"Adv Digest Med"},{"key":"10.1016\/j.jfma.2023.10.018_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jmv.20771","article-title":"Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program","volume":"79","author":"Su","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfma.2023.10.018_bib43","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/liv.13437","article-title":"Higher disappearance rate of anti-HBs in Taiwanese freshers neonatally vaccinated with recombinant yeast hepatitis B vaccine","volume":"37","author":"Hsu","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2023.10.018_bib44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.vaccine.2003.09.001","article-title":"Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers","volume":"22","author":"Floreani","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2023.10.018_bib45","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.vaccine.2009.01.027","article-title":"Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan","volume":"27","author":"Kao","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jfma.2023.10.018_bib46","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1542\/peds.2007-0131","article-title":"Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy","volume":"120","author":"Samandari","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jfma.2023.10.018_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14218\/JCTH.2015.00026","article-title":"The role of immune cells in chronic HBV infection","volume":"3","author":"Li","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jfma.2023.10.018_bib48","first-page":"598","article-title":"Gender disparity in infections of Hepatitis B virus","volume":"19","author":"Baig","year":"2009","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.jfma.2023.10.018_bib49","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.3389\/fimmu.2018.02302","article-title":"Sex-dependent outcome of hepatitis B and C viruses infections: Synergy of sex hormones and immune responses?","volume":"9","author":"Ruggieri","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jfma.2023.10.018_bib50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/acel.12326","article-title":"How sex and age affect immune responses, susceptibility to infections, and response to vaccination","volume":"14","author":"Giefing-Kr\u00f6ll","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.jfma.2023.10.018_bib51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/tropej\/40.2.104","article-title":"Female children respond to recombinant hepatitis B vaccine with a higher titre than male","volume":"40","author":"Fang","year":"1994","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jfma.2023.10.018_bib52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/14760584.2017.1338568","article-title":"The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience","volume":"16","author":"Van Den Ende","year":"2017","journal-title":"Expert Rev Vaccines"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623004369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623004369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T18:04:27Z","timestamp":1720721067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623004369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0929664623004369"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.10.018","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The seroepidemiology of isolated core antibody against hepatitis B among Taiwanese adults - A large hospital-based study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights reserved.","name":"copyright","label":"Copyright"}]}}